{"author_id": "847441863875284992", "created_at": "2021-05-24T22:22:36.000Z", "text": "RT @HeroDividend: \ud83d\udcb010 Dividend Growth Stocks\ud83d\udcb0\n\n$V \ud83d\udcb3\n$PG \ud83e\uddfc\n$HD \ud83d\udc77\ud83c\udffb\u200d\u2642\ufe0f\n$WM \u267b\ufe0f\n$TGT \ud83d\udecd\n$TXN \ud83c\udfd9\n$JPM  \ud83c\udfe6\n$ABBV \ud83d\udc8a\n$MSFT  \u2601\ufe0f\n$COST  \ud83d\uded2", "id": "1396954814672556032"}
{"created_at": "2021-05-24T13:20:32.000Z", "text": "$ABBV AbbVie Presents New Late-Breaking Data Analyses Showing Risankizumab (SKYRIZI\u00ae) Achieves Clinical Remission and Endoscopic Response at Week 12 in Patients with Moderate to Severe Crohn\u2019s Disease https://t.co/zhlkToZcrm", "id": "1396818397703380993", "author_id": "472650465"}
